Showing results (6651-6660 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 16, 2009
Multifunctional antimicrobial proteins and peptides: natural activators of immune systemsFrançois Niyonsaba, Isao Nagaoka, Hideoki Ogawa, et al.Current Pharmaceutical Design|July 16, 2009
Peptides as signaling inhibitors for mammalian MAP kinase cascadesMatthias Gaestel, Michael KrachtCurrent Pharmaceutical Design|April 8, 2010
FMRI, antipsychotics and schizophrenia. Influence of different antipsychotics on BOLD-signalChristian H Röder, Janna Marie Hoogendam, Frederik M van der VeenCurrent Pharmaceutical Design|April 8, 2010
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disordersAlexander R Moschen, Romana R Gerner, Herbert TilgCurrent Pharmaceutical Design|April 8, 2010
Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosisHerbert TilgCurrent Pharmaceutical Design|April 8, 2010
Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver diseaseAnke Tönjes, Matthias Blüher, Michael StumvollCurrent Pharmaceutical Design|April 8, 2010
Current and future therapeutic strategies in NAFLDNimantha Mark, Wilfred de Alwis, Christopher Paul DayCurrent Pharmaceutical Design|April 14, 2007
Current diagnostic modalities for vulnerable plaque detectionJohannes A Schaar, Frits Mastik, Evelyn Regar, et al.Current Pharmaceutical Design|April 14, 2007
PACAP in the glucose and energy homeostasis: physiological role and therapeutic potentialMasanori Nakata, Toshihiko YadaPageof 1,008